UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 11, 2004
| 0-29630 | 98-0359573 |
| (Commission File Number) | (I.R.S. Employer Identification No.) |
| Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP England | |
| (Address of principal executive offices) | (Zip code) |
Registrant’s telephone number, including area code 44 1256 894 000
Item 7. Financial Statements and Exhibits
(c) Exhibits. The following exhibit is filed herewith:
99.1 Press Release of Shire Pharmaceuticals Group plc dated March 11, 2004, reporting Shire's financial results for the fourth quarter of 2003 and the year ended December 31, 2003.
Item 12. Results of Operations and Financial Condition
On March 11, 2004, Shire Pharmaceuticals Group plc issued a press release announcing its financial results for the fourth quarter of 2003 and the year ended December 31, 2003. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SHIRE PHARMACEUTICALS GROUPPLC By: /s/ A C Russell |
Dated: March 11, 2004
EXHIBIT INDEX
| Number | Description | |
| 99.1 | Press Release of Shire Pharmaceuticals Group plc dated March 11, 2004, reporting Shire’s financial results for the fourth quarter of 2003 and the year ended December 31, 2003. | |
